Biovaxys Technology Corp
CNSX:BIOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biovaxys Technology Corp
CNSX:BIOV
|
CA |
|
B
|
Bavarian Nordic A/S
OTC:BVNRY
|
DK |
|
D
|
Develia SA
WSE:DVL
|
PL |
|
S
|
Strategic Education Inc
F:SQE
|
US |
|
N
|
NextDecade Corp
F:2XD
|
US |
|
M
|
Marketaxess Holdings Inc
F:MWI
|
US |
|
P
|
Prinsiri PCL
SET:PRIN
|
TH |
|
Netcompany Group A/S
CSE:NETC
|
DK |
|
Etruscus Resources Corp
OTC:ETRUF
|
CA |
|
Delota Corp
F:S62
|
CA |
|
Mid Penn Bancorp Inc
NASDAQ:MPB
|
US |
|
G
|
Galan Lithium Ltd
F:9CH
|
AU |
|
Nexi SpA
F:N0X0
|
IT |
|
Puradelta Lestari Tbk PT
OTC:PTPLF
|
ID |
Intrinsic Value
Is BIOV undervalued or overvalued?
See the intrinsic value estimate for Biovaxys Technology Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
BIOV looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with BIOV’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Biovaxys Technology Does
BioVaxys Technology Corp. is a clinical stage biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-11-21. The firm is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergies, and other immunological diseases.
- Headquarters
- Canada CA
- IPO date
- Nov 21, 2018
Earnings Waterfall
Biovaxys Technology Corp
The intrinsic value for Biovaxys Technology Corp (BIOV) under the Base Case is hidden CAD.
Compared with the current market price of 0.07 CAD, the stock appears hidden.